Alpha 2.0
Login Register
» Authors » Fahmida Shaik

Fahmida Shaik

Explore the profile of Fahmida Shaik including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 137
Followers 0
Related Specialties
Infectious Diseases
Oncology
Biomedical Engineering
Top 10 Co-Authors
Anisa Mosam
Thomas S Uldrick
Salma Younas
Sweta Sahu
Tonya Esterhuizen
Thomas B Campbell
Gerald H Friedland
Swati Thareja
Philippa J Easterbrook
James J Lewis
Published In
Cureus
J Acquir Immune Defic Syndr
Trop Med Infect Dis
AIDS
J Glob Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Efficacy of Non-invasive Biomarkers in Diagnosing Non-alcoholic Fatty Liver Disease (NAFLD) and Predicting Disease Progression: A Systematic Review
Garg S, Varghese M, Shaik F, Jatin F, Sachdeva D, Wafa Eranhikkal F, et al.
Cureus . 2025 Mar; 17(2):e78421. PMID: 40046382
Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with significant global prevalence and a strong association with metabolic syndrome, obesity, and diabetes. Early diagnosis and...
2.
Impact of Obstructive Sleep Apnea on Cardiovascular Health: A Systematic Review
Thareja S, Mandapalli R, Shaik F, Rajeev Pillai A, Palaniswamy G, Sahu S, et al.
Cureus . 2024 Nov; 16(10):e71940. PMID: 39564053
Obstructive sleep apnea (OSA) is characterized by recurrent interruptions in breathing during sleep and is associated with a wide range of significant health concerns, particularly cardiovascular complications. This review focuses...
3.
Early Changes in Health-Related Quality of Life as a Biomarker of Survival in African Patients with HIV-Associated Kaposi Sarcoma
Shaik F, Uldrick T, Mazinu M, Gwebushe N, Mosam A
Trop Med Infect Dis . 2024 Oct; 9(10). PMID: 39453271
Sub-Saharan Africa bears the largest public health burden of Kaposi sarcoma (KS), a leading cause of cancer mortality. Quality of life (QOL) assessments in cancer patients can provide information on...
4.
Health-Related Quality of Life in Patients Treated With Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for HIV-Associated Kaposi Sarcoma: A Randomized Control Trial
Shaik F, Uldrick T, Esterhuizen T, Mosam A
J Glob Oncol . 2018 Oct; 4:1-9. PMID: 30354935
Purpose: In sub-Saharan Africa, Kaposi sarcoma (KS) is the most common HIV-associated cancer. KS causes substantial morbidity, and treatment goals should emphasize quality of life (QOL). Antiretroviral therapy (ART) is...
5.
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK
Letang E, Lewis J, Bower M, Mosam A, Borok M, Campbell T, et al.
AIDS . 2013 Mar; 27(10):1603-13. PMID: 23462220
Objectives: To assess the incidence, predictors, and outcomes of Kaposi sarcoma-associated paradoxical immune reconstitution inflammatory syndrome (KS-IRIS) in antiretroviral therapy (ART)-naive HIV-infected patients with Kaposi sarcoma initiating ART in both...
6.
A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa
Mosam A, Shaik F, Uldrick T, Esterhuizen T, Friedland G, Scadden D, et al.
J Acquir Immune Defic Syndr . 2012 Mar; 60(2):150-7. PMID: 22395672
Background: The optimal approach to HIV-associated Kaposi sarcoma (HIV-KS) in sub-Saharan Africa is unknown. With large-scale rollout of highly active antiretroviral therapy (HAART) in South Africa, we hypothesized that survival...